Clinical Trial Update: Study on the Safety of Drug BAY2586116 and How it Works in Patients With Obstructive Sleep Apnea (a Sleep Disorder Caused by the Narrowing and Collapse of the Airway During Sleep) Including the Blood Level of the Drug and Effect of Its Doses and Routes of Administration [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating the safety, pharmacokinetics, and dosing of BAY2586116 in adults with obstructive sleep apnea.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obstructive Sleep Apnea

Drugs mentioned

• BAY2586116

Snippet

Sponsor: Bayer | Conditions: Sleep Apnea, Obstructive | Phase 2 | Status: COMPLETED